scispace - formally typeset
X

Xun Hu

Researcher at Zhejiang University

Publications -  22
Citations -  3344

Xun Hu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Cancer & Cancer cell. The author has an hindex of 16, co-authored 20 publications receiving 3191 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Daniel J. Klionsky, +235 more
- 16 Feb 2008 - 
TL;DR: A set of guidelines for the selection and interpretation of the methods that can be used by investigators who are attempting to examine macroautophagy and related processes, as well as by reviewers who need to provide realistic and reasonable critiques of papers that investigate these processes are presented.
Journal ArticleDOI

Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis

TL;DR: It is shown that shikonin-induced necroptosis can be reverted to apoptosis in the presence of necrostatin-1 (Nec-1), a specific ne croptosis inhibitor and that the death mode switch is at least partially due to the conversion from mitochondrial inner membrane permeability to mitochondrial outer membrane permeable, which is associated with Bax translocation.
Journal ArticleDOI

Naturally-occurring shikonin analogues--a class of necroptotic inducers that circumvent cancer drug resistance.

TL;DR: It is shown that the naturally-occurring shikonin analogues could bypass drug resistance mediated by not only P-gp, Bcl-2, and BCl-xL, but also two additional important drug-resistant factors MRP1 and BCRP1, by induction of necroptosis.
Journal ArticleDOI

No evident dose-response relationship between cellular ROS level and its cytotoxicity – a paradoxical issue in ROS-based cancer therapy

TL;DR: This study randomly chose 4 cancer cell lines and primary colon or rectal cancer cells from 4 patients to test the hypothesis of a dose-response relationship between cellular ROS level and cytotoxicity and obtained paradoxical results.
Journal ArticleDOI

Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol

TL;DR: It is shown that Honokiol down-regulated the expression of P-glycoprotein at mRNA and protein levels in MCF-7/ADR, a human breast MDR cancer cell line, revealing a novel function of honokiol as an anti-cancer agent.